NDC 70859-033 Nudroxipak Dsdr-50

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
70859-033
Proprietary Name:
Nudroxipak Dsdr-50
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Nucare Pharmaceuticals, Inc.
Labeler Code:
70859
Start Marketing Date: [9]
03-12-2018
Listing Expiration Date: [11]
12-31-2022
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
Shape:
ROUND (C48348)
Size(s):
9 MM
Imprint(s):
R;550
Score:
1

Product Packages

NDC Code 70859-033-01

Package Description: 1 KIT in 1 CARTON * 1 CONTAINER in 1 CARTON (70859-028-03) / 90 mL in 1 CONTAINER * 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0228-2550-06)

Product Details

What is NDC 70859-033?

The NDC code 70859-033 is assigned by the FDA to the product Nudroxipak Dsdr-50 which is product labeled by Nucare Pharmaceuticals, Inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 70859-033-01 1 kit in 1 carton * 1 container in 1 carton (70859-028-03) / 90 ml in 1 container * 60 tablet, delayed release in 1 bottle (0228-2550-06). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Nudroxipak Dsdr-50?

Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation) . Diclofenac sodium delayed-release tablets, USP are indicated:For relief of the signs and symptoms of osteoarthritisFor relief of the signs and symptoms of rheumatoid arthritisFor acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis

Which are Nudroxipak Dsdr-50 UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Nudroxipak Dsdr-50 Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Nudroxipak Dsdr-50?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1989491 - capsaicin 0.025 % / menthol 6 % / methyl salicylate 25 % Topical Solution
  • RxCUI: 1989491 - capsaicin 0.25 MG/ML / menthol 60 MG/ML / methyl salicylate 250 MG/ML Topical Solution
  • RxCUI: 855906 - diclofenac sodium 50 MG Delayed Release Oral Tablet

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".